Each year, 500 to 1,000 people in the United States are diagnosed with pulmonary arterial hypertension (PAH), a rare lung ...

The Social Security Administration has tasked the National Academies of Sciences, Engineering, and Medicine to review the latest published research and science and produce a report addressing best ...

Courtney Southwick is a writer focusing on health, nutrition, and disease. She has been blogging for the past two years at CourtneySouthwick.com. She writes blogs and articles for online publications ...

CLEVELAND — November is Lung Cancer Awareness month. The disease is the leading cause of cancer death around the world, and according to the American Lung Association, nearly a quarter of a million ...

Please provide your email address to receive an email when new articles are posted on . Acceptance and utilization of lung cancer biomarker testing has increased in the past 6 years, but key barriers ...

Jessica Donington, MD, MSCR: There’s one more factor that in 2021 plays a huge role in how we determine upfront treatment and treatment plans altogether and that’s something called molecular testing.

ATLANTA, Georgia — A combination of gene-expression testing (BronchoGen, Allegro Diagnostics) and diagnostic bronchoscopy significantly improves accuracy in the diagnosis of lung cancer, compared with ...

Pulmonary function tests for the early diagnosis of chronic obstructive pulmonary disease will be included in Korea's national health screening program for the first time next year.

Dr. Joshua K. Sabari sat down with Terri Conneran at the 2025 World Conference on Lung Cancer for a conversation on the importance of biomarker testing.

During our third Respiratory Day last week, our Lung Health Champions travelled from across the country to Washington, D.C., ...